Compare stocks side-by-side
Compare DNLI vs RXRX on price performance, valuation, growth and AI ratings.
Compare DNLI, RXRX on price performance, valuation, growth and AI ratings. Up to 5 stocks.
| Metric | DNLI | RXRX |
|---|---|---|
| Valuation | ||
| Price | $19.29 | $4.35 |
| Market cap | 3.08B | 2.60B |
| EPS | $-3.21 | $-1.08 |
| Fair value | $16.14 | – |
| Upside | -16.35% | – |
| Growth | ||
| Day change | +0.36% | +7.41% |
| 1 month | -8.06% | +17.57% |
| 3 months | -19.79% | +42.62% |
| 6 months | -3.84% | +27.57% |
| Year to date | +16.84% | +6.36% |
| 1 year | +14.01% | -26.40% |
| 5 years | -60.57% | -77.53% |
| Revenue growth | +204.74% | +26.92% |
| Profitability | ||
| Gross margin | -61.04% | -46.66% |
| Operating margin | -150.58% | -9.92% |
| Net margin | -141.91% | -9.46% |
| ROE | -55.27% | -50.41% |
| Dividends | ||
| Dividend yield | 0.00% | 0.00% |
| Payout ratio | 0.00% | 0.00% |
| Stocklytics | ||
| Score | – | 47.00 |
| Sentiment | – | Neutral |